Skip to content
DeepViews

Ametek, Inc. (AME) — Analysis Summary

Ametek, Inc. (AME) has a market cap of $53.92B with year-over-year revenue growth of +6.6%. Net margin stands at 20.0%. The stock trades at a P/E ratio of 34.2.

Key Takeaways

  • Revenue changed +6.6% year-over-year
  • Net margin of 20.0%
  • P/E ratio of 34.2

Compared to other companies in the INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL sector, AME posted revenue growth of +6.6% and trades at a P/E of 34.2.

[XNYS]

Ametek, Inc. (AME)

$235.17

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$53.92B
Enterprise Value
$55.46B
P/E Ratio
34.2
Div Yield
0.58%
EV/EBITDA
22.6
Company Profile
About
About Ametek, Inc.

Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets it operates in.

Sector

INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL

Employees

22,500

Headquarters

BERWYN, PA

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
67
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$11.26B
Total Debt$2036.17M
Debt-to-Equity0.18
Cash & Equivalents$495.45M

Cash Flow

Operating Cash Flow$1960.34M
Free Cash Flow$1824.95M
FCF Margin23.21%
P/FCF Ratio29.54
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$1.36

Dividend Yield

0.58%

Quarterly
Last Ex-Date: 2026-09-15

Dividend History

2026-09-15
CD$0.3400
2026-06-15
CD$0.3400
2026-03-16
CD$0.3400
2025-12-05
CD$0.3100
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.